Navigation Links
USAID awards cooperative agreement to CONRAD for multipurpose prevention study
Date:10/13/2011

Arlington, VA -- USAID awarded CONRAD a five year project with a $2 million ceiling to focus on testing the safety and effectiveness of the SILCS diaphragm, the one-size-fits-most contraceptive barrier, combined with tenofovir gel -- the only topical product proven to prevent the acquisition of HIV and Herpes Simplex Virus (HSV). If shown to be safe, effective and acceptable, this combination of products would provide women with a non-hormonal contraceptive method under their own control that also delivers protection against HIV and HSV. This award supports Aim 2 of USAID's Biomedical Research for Reproductive Health: to fast track development of reproductive health technologies that can simultaneously prevent unintended pregnancy, HIV, and other sexually transmitted infections.

Results of the SILCS diaphragm contraceptive effectiveness study were announced last month and showed effectiveness rates similar to that of a traditional fitted diaphragm. The benefits of this single size diaphragm include eliminating the need for a pelvic exam to fit the diaphragm, and meeting the contraceptive needs of women unable or unwilling to use a hormonal method.

In a recent landmark effectiveness trial conducted by CAPRISA in South Africa, tenofovir gel was shown to reduce the risk of HIV infection by 39% and HSV by 51%. Confirmatory studies of the gel are ongoing and will support regulatory approval.

Dr. Henry Gabelnick, CONRAD's Executive Director said, "We see an urgent need for multipurpose prevention technologies, including non-hormonal methods that are easy to use, and that can be combined with a product that reduces the risk of HIV and HSV infection. This type of reproductive health technology is particularly needed in areas of the world where women need easy to use methods that are within their control."

Almost half of all pregnancies worldwide, estimated to be over 100 million annually, are unintended. In 2008, this resulted in 43 million abortions, half of which were performed under unsafe conditions, leading to almost 100,000 maternal deaths and 5 million women left with temporary or permanent disabilities. The majority of these deaths occur in less developed countries where the AIDS epidemic is most prevalent.

The SILCS diaphragm was developed at PATH, an international nonprofit organization whose mission is to improve the health of people around the world. PATH and CONRAD have collaborated on the validation of the SILC diaphragm for regulatory approval as a contraceptive device. CONRAD has been developing new methods of contraception for men and women for 25 years, including hormonal methods and barrier devices such as the female condom and cervical caps.
'/>"/>

Contact: Annette Larkin
alarkin@conrad.org
703-772-6427
CONRAD
Source:Eurekalert

Related medicine news :

1. The Coca-Cola Company and USAID Expand Global Water Partnership
2. Aid Agency World Vision Granted $19m From USAID/OFDA for Haiti
3. US Army awards $1.5 million for sleep research
4. Georgia Tech researchers receive 3 NSF Emerging Frontiers awards
5. 2 scientists at the University of Texas at Austin receive early career awards from White House
6. US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research
7. University Hospitals Case Medical Center awarded 2011 fellowship awards for pain medicine, epilepsy
8. NCI awards $19.3m for multisite investigation of cancer disparities
9. Elsevier congratulates Dr. Charles Silverstein upon his receipt of 2 awards
10. NIH awards WSU researcher $1.39M to study chromatins role in cell division
11. BIDMC scientists receive Challenge Awards from Prostate Cancer Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... Apptricity® Corporation, a ... and spend management, today announced that Keppel Corporation has selected Apptricity Travel and ... , “We are excited to announce the partnership between Keppel and Apptricity ...
(Date:2/21/2017)... ... 21, 2017 , ... Hanna Boys Center http://www.hannacenter.org ... the keynote speaker at its second Professional Networking Breakfast on March 9, 2017. ... comprehensive strategies to create and expand opportunities for boys and young men of ...
(Date:2/21/2017)... ... ... Support of value-based care models requires collaboration across all facets of the ... Fogo Data Centers announces the launch of the Fogo Partner Community™. , At Fogo, ... which all systems work well, work together, and work together well. In healthcare, ...
(Date:2/21/2017)... ... February 21, 2017 , ... HIMSS is ... connected care demonstration spanned multiple health information systems including OpenEMR, EMRDirect, and ... providers have no Health Information Exchange outside of faxing. Medal’s innovative technology “meets ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... the rate at which women are called back for additional examinations without sacrificing ... Radiology . , In 2011, the U.S. Food and Drug Administration approved digital ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Feb. 21, 2017 Auburn University College of Veterinary ... acquire a Hyperbaric Veterinary Medicine (HVM) Chamber.  The University of ... in its small animal hospital, and now Auburn University will ... oxygen chamber that is engineered exclusively for the treatment of ... chambers in such highly revered universities like Auburn ...
(Date:2/21/2017)... YORK , Feb. 21, 2017 Diabetic Shoes ... ... Diabetes can be described as a disease, which is marked ... insulin production and insulin action. The disease has become a ... premature death. Diabetes affects several organs of the body including ...
(Date:2/21/2017)... 2017 Medical Oxygen Concentrators Market: Overview ... Medical oxygen concentrators are used by ... Patients having low level of oxygen in their ... concentrators are to be used only with prescription ... oxygen concentrators work either on rechargeable lithium batteries ...
Breaking Medicine Technology: